Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shaf Keshavjee

Showing results (551-560 of 564) with videos related to

Pageof 57
Sort By:
Intensive Care Medicine|February 26, 2021
Expanding controlled donation after the circulatory determination of death: statement from an international collaborativeBeatriz Domínguez-Gil, Nancy Ascher, Alexander M Capron, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 29, 2019
Donation after circulatory death in lung transplantation-five-year follow-up from ISHLT RegistryDirk Van Raemdonck, Shaf Keshavjee, Bronwyn Levvey, et al.
The Lancet. Gastroenterology & Hepatology|May 12, 2020
Short-course, direct-acting antivirals and ezetimibe to prevent HCV infection in recipients of organs from HCV-infected donors: a phase 3, single-centre, open-label studyJordan J Feld, Marcelo Cypel, Deepali Kumar, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 4, 2020
Bronchoalveolar bile acid and inflammatory markers to identify high-risk lung transplant recipients with reflux and microaspirationChen Yang Kevin Zhang, Musawir Ahmed, Ella Huszti, et al.
Journal of Virology|June 1, 2007
Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndromeMark J Cameron, Longsi Ran, Luoling Xu, et al.
The Lancet. Respiratory Medicine|October 14, 2019
Prevention of viral transmission during lung transplantation with hepatitis C-viraemic donors: an open-label, single-centre, pilot trialMarcelo Cypel, Jordan J Feld, Marcos Galasso, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 23, 2026
Identifying patients with high risk stage I NSCLC using tumor-informed plasma ctDNAJamie Feng, Sameena Khan, Thomas Waddell, et al.
Pulmonary Circulation|April 25, 2025
Approach to Lung Transplantation in Pulmonary Arterial Hypertension: A Delphi Consensus on Behalf of the Transplant Task Force of the Pulmonary Vascular Research InstituteNicholas A Kolaitis, Hayley Barnes, Deborah J Levine, et al.
The Annals of Thoracic Surgery|April 13, 2020
COVID-19 Guidance for Triage of Operations for Thoracic Malignancies: A Consensus Statement From Thoracic Surgery Outcomes Research Network, Mara Antonoff, Leah Backhus, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 22, 2020
COVID-19 guidance for triage of operations for thoracic malignancies: A consensus statement from Thoracic Surgery Outcomes Research Network, Mara Antonoff, Leah Backhus, et al.
Pageof 57

Showing results (551-560 of 564) with videos related to

Sort By:
Pageof 57
Intensive Care Medicine|February 26, 2021
Expanding controlled donation after the circulatory determination of death: statement from an international collaborativeBeatriz Domínguez-Gil, Nancy Ascher, Alexander M Capron, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 29, 2019
Donation after circulatory death in lung transplantation-five-year follow-up from ISHLT RegistryDirk Van Raemdonck, Shaf Keshavjee, Bronwyn Levvey, et al.
The Lancet. Gastroenterology & Hepatology|May 12, 2020
Short-course, direct-acting antivirals and ezetimibe to prevent HCV infection in recipients of organs from HCV-infected donors: a phase 3, single-centre, open-label studyJordan J Feld, Marcelo Cypel, Deepali Kumar, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 4, 2020
Bronchoalveolar bile acid and inflammatory markers to identify high-risk lung transplant recipients with reflux and microaspirationChen Yang Kevin Zhang, Musawir Ahmed, Ella Huszti, et al.
Journal of Virology|June 1, 2007
Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndromeMark J Cameron, Longsi Ran, Luoling Xu, et al.
The Lancet. Respiratory Medicine|October 14, 2019
Prevention of viral transmission during lung transplantation with hepatitis C-viraemic donors: an open-label, single-centre, pilot trialMarcelo Cypel, Jordan J Feld, Marcos Galasso, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 23, 2026
Identifying patients with high risk stage I NSCLC using tumor-informed plasma ctDNAJamie Feng, Sameena Khan, Thomas Waddell, et al.
Pulmonary Circulation|April 25, 2025
Approach to Lung Transplantation in Pulmonary Arterial Hypertension: A Delphi Consensus on Behalf of the Transplant Task Force of the Pulmonary Vascular Research InstituteNicholas A Kolaitis, Hayley Barnes, Deborah J Levine, et al.
The Annals of Thoracic Surgery|April 13, 2020
COVID-19 Guidance for Triage of Operations for Thoracic Malignancies: A Consensus Statement From Thoracic Surgery Outcomes Research Network, Mara Antonoff, Leah Backhus, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 22, 2020
COVID-19 guidance for triage of operations for thoracic malignancies: A consensus statement from Thoracic Surgery Outcomes Research Network, Mara Antonoff, Leah Backhus, et al.
Pageof 57